Wounds Skin and Connective Tissue Diseases Wounds
Conditions
Interventions
Eakin wound dressing will be trialled against a leading hydrocolloid wound dressing for a period of 5 weeks or until the wound has healed. Dressings will be changed every 4 days.
Sponsors
TG Eakin Limited (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All patients presenting superficial/partial thickness wounds which could or would normally be treated with a 'hydrocolloid' wound dressing, and who are not precluded by the exclusion criteria below, will be invited to participate in this clinical trial.
Exclusion criteria
Exclusion criteria: Patients will be excluded from the trial under the following circumstances: 1. Wound is >5 cm length or breadth 2. Wound is >0.5 cm depth 3. Wound involving muscle, tendon or bone 4. Wound infection is suspected 5. Where informed consent is withheld 6. Where patients are unable to give informed consent due to legal incompetence, unless informed consent is available from a responsible relative or guardian 7. Where, in the physician's opinion, inclusion in the trial is not advised
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Confirmation of the clinical efficacy and safety of Eakin wound dressing when used in the treatment of superficial/partial thickness wounds. Wound is healed (or reduced in size) over a period of 5 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed